ID S36A2_MOUSE Reviewed; 478 AA. AC Q8BHK3; Q8BUB0; Q8JZP1; DT 18-MAR-2008, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2003, sequence version 1. DT 27-MAR-2024, entry version 145. DE RecName: Full=Proton-coupled amino acid transporter 2 {ECO:0000305|PubMed:11959859}; DE Short=Proton/amino acid transporter 2 {ECO:0000303|PubMed:11959859}; DE AltName: Full=Solute carrier family 36 member 2 {ECO:0000312|MGI:MGI:1891430}; DE AltName: Full=Transmembrane domain rich protein 1 {ECO:0000303|PubMed:12451123}; DE Short=Tramdorin-1 {ECO:0000303|PubMed:12451123}; GN Name=Slc36a2 {ECO:0000312|MGI:MGI:1891430}; GN Synonyms=Pat2 {ECO:0000303|PubMed:11959859}, Tramd1 GN {ECO:0000303|PubMed:12451123}; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TRANSPORTER ACTIVITY, RP BIOPHYSICOCHEMICAL PROPERTIES, AND SUBCELLULAR LOCATION. RC STRAIN=C57BL/6J; RX PubMed=11959859; DOI=10.1074/jbc.m200374200; RA Boll M., Foltz M., Rubio-Aliaga I., Kottra G., Daniel H.; RT "Functional characterization of two novel mammalian electrogenic proton- RT dependent amino acid cotransporters."; RL J. Biol. Chem. 277:22966-22973(2002). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC STRAIN=C57BL/6J; RX PubMed=12451123; DOI=10.1523/jneurosci.22-23-10217.2002; RA Bermingham J.R. Jr., Shumas S., Whisenhunt T., Sirkowski E.E., RA O'Connell S., Scherer S.S., Rosenfeld M.G.; RT "Identification of genes that are downregulated in the absence of the POU RT domain transcription factor pou3f1 (Oct-6, Tst-1, SCIP) in sciatic nerve."; RL J. Neurosci. 22:10217-10231(2002). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC STRAIN=C57BL/6J, and NOD; TISSUE=Head; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC STRAIN=FVB/N; TISSUE=Salivary gland; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP FUNCTION, TRANSPORTER ACTIVITY, AND TISSUE SPECIFICITY. RX PubMed=12809675; DOI=10.1016/s0888-7543(03)00099-5; RA Boll M., Foltz M., Rubio-Aliaga I., Daniel H.; RT "A cluster of proton/amino acid transporter genes in the human and mouse RT genomes."; RL Genomics 82:47-56(2003). RN [7] RP FUNCTION, AND TRANSPORTER ACTIVITY. RX PubMed=15291811; DOI=10.1111/j.1432-1033.2004.04268.x; RA Foltz M., Oechsler C., Boll M., Kottra G., Daniel H.; RT "Substrate specificity and transport mode of the proton-dependent amino RT acid transporter mPAT2."; RL Eur. J. Biochem. 271:3340-3347(2004). RN [8] RP FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, AND TISSUE RP SPECIFICITY. RX PubMed=14600155; DOI=10.1074/jbc.m305556200; RA Rubio-Aliaga I., Boll M., Vogt Weisenhorn D.M., Foltz M., Kottra G., RA Daniel H.; RT "The proton/amino acid cotransporter PAT2 is expressed in neurons with a RT different subcellular localization than its paralog PAT1."; RL J. Biol. Chem. 279:2754-2760(2004). RN [9] RP TISSUE SPECIFICITY. RX PubMed=15058382; DOI=10.1007/s00335-003-2319-3; RA Bermingham J.R. Jr., Pennington J.; RT "Organization and expression of the SLC36 cluster of amino acid transporter RT genes."; RL Mamm. Genome 15:114-125(2004). RN [10] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brown adipose tissue, and Lung; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Electrogenic proton/amino acid symporter with a high CC selectivity for the small side chains amino acids glycine, alanine and CC proline, where both L- and D-enantiomers are transported. Extension of CC the backbone length, as in beta-alanine and 4-aminobutanoate or CC methylation of the amino group, as in sarcosine and N,N- CC dimethylglycine, are also tolerated but decrease transport efficiency. CC A free carboxyl group is preferred. {ECO:0000269|PubMed:11959859, CC ECO:0000269|PubMed:12809675, ECO:0000269|PubMed:14600155, CC ECO:0000269|PubMed:15291811}. CC -!- CATALYTIC ACTIVITY: CC Reaction=glycine(in) + H(+)(in) = glycine(out) + H(+)(out); CC Xref=Rhea:RHEA:28899, ChEBI:CHEBI:15378, ChEBI:CHEBI:57305; CC Evidence={ECO:0000269|PubMed:11959859, ECO:0000269|PubMed:14600155, CC ECO:0000269|PubMed:15291811}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H(+)(in) + L-alanine(in) = H(+)(out) + L-alanine(out); CC Xref=Rhea:RHEA:29443, ChEBI:CHEBI:15378, ChEBI:CHEBI:57972; CC Evidence={ECO:0000269|PubMed:11959859, ECO:0000269|PubMed:15291811}; CC -!- CATALYTIC ACTIVITY: CC Reaction=D-alanine(in) + H(+)(in) = D-alanine(out) + H(+)(out); CC Xref=Rhea:RHEA:28903, ChEBI:CHEBI:15378, ChEBI:CHEBI:57416; CC Evidence={ECO:0000269|PubMed:11959859, ECO:0000269|PubMed:15291811}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H(+)(out) + L-proline(out) = H(+)(in) + L-proline(in); CC Xref=Rhea:RHEA:28963, ChEBI:CHEBI:15378, ChEBI:CHEBI:60039; CC Evidence={ECO:0000269|PubMed:11959859, ECO:0000269|PubMed:12809675, CC ECO:0000269|PubMed:15291811}; CC -!- CATALYTIC ACTIVITY: CC Reaction=D-proline(out) + H(+)(out) = D-proline(in) + H(+)(in); CC Xref=Rhea:RHEA:70643, ChEBI:CHEBI:15378, ChEBI:CHEBI:57726; CC Evidence={ECO:0000269|PubMed:15291811}; CC -!- CATALYTIC ACTIVITY: CC Reaction=4-hydroxy-L-proline(in) + H(+)(in) = 4-hydroxy-L-proline(out) CC + H(+)(out); Xref=Rhea:RHEA:70663, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:58419; Evidence={ECO:0000269|PubMed:15291811}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H(+)(in) + L-serine(in) = H(+)(out) + L-serine(out); CC Xref=Rhea:RHEA:28887, ChEBI:CHEBI:15378, ChEBI:CHEBI:33384; CC Evidence={ECO:0000269|PubMed:11959859}; CC -!- CATALYTIC ACTIVITY: CC Reaction=D-serine(out) + H(+)(out) = D-serine(in) + H(+)(in); CC Xref=Rhea:RHEA:70647, ChEBI:CHEBI:15378, ChEBI:CHEBI:35247; CC Evidence={ECO:0000269|PubMed:11959859, ECO:0000269|PubMed:15291811}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-alanine(in) + H(+)(in) = beta-alanine(out) + H(+)(out); CC Xref=Rhea:RHEA:29459, ChEBI:CHEBI:15378, ChEBI:CHEBI:57966; CC Evidence={ECO:0000269|PubMed:11959859, ECO:0000269|PubMed:15291811}; CC -!- CATALYTIC ACTIVITY: CC Reaction=4-aminobutanoate(in) + H(+)(in) = 4-aminobutanoate(out) + CC H(+)(out); Xref=Rhea:RHEA:28915, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:59888; Evidence={ECO:0000269|PubMed:11959859, CC ECO:0000269|PubMed:15291811}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H(+)(in) + sarcosine(in) = H(+)(out) + sarcosine(out); CC Xref=Rhea:RHEA:70655, ChEBI:CHEBI:15378, ChEBI:CHEBI:57433; CC Evidence={ECO:0000269|PubMed:15291811}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H(+)(in) + N,N-dimethylglycine(in) = H(+)(out) + N,N- CC dimethylglycine(out); Xref=Rhea:RHEA:70659, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:58251; Evidence={ECO:0000269|PubMed:15291811}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=0.59 mM for glycine {ECO:0000269|PubMed:11959859}; CC KM=0.26 mM for L-alanine {ECO:0000269|PubMed:11959859}; CC KM=0.12 mM for L-proline {ECO:0000269|PubMed:11959859}; CC KM=43 mM for L-serine {ECO:0000269|PubMed:11959859}; CC KM=6.5 mM for D-alanine {ECO:0000269|PubMed:11959859}; CC KM=30.9 mM for 4-aminobutanoate/GABA {ECO:0000269|PubMed:11959859}; CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11959859, CC ECO:0000269|PubMed:14600155}; Multi-pass membrane protein CC {ECO:0000255}. Endoplasmic reticulum membrane CC {ECO:0000269|PubMed:14600155}. Recycling endosome membrane CC {ECO:0000269|PubMed:14600155}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q8BHK3-1; Sequence=Displayed; CC Name=2; CC IsoId=Q8BHK3-2; Sequence=VSP_032374, VSP_032375; CC -!- TISSUE SPECIFICITY: Expressed in spinal cord, brain, testis, lung, CC heart, colon, spleen, kidney and muscle. Found in neuronal cell bodies CC in the anterior horn, in spinal cord brain stem, cerebellum, CC hippocampus, hypothalamus, rhinencephalon, cerebral cortex, and CC olfactory bulb in the brain. Also expressed in bone and fat tissues. CC {ECO:0000269|PubMed:12809675, ECO:0000269|PubMed:14600155, CC ECO:0000269|PubMed:15058382}. CC -!- SIMILARITY: Belongs to the amino acid/polyamine transporter 2 family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF453744; AAM80481.1; -; mRNA. DR EMBL; AF512429; AAM44854.1; -; mRNA. DR EMBL; AK041041; BAC30795.1; -; mRNA. DR EMBL; AK079053; BAC37515.1; -; mRNA. DR EMBL; AK086373; BAC39656.1; -; mRNA. DR EMBL; AK156409; BAE33702.1; -; mRNA. DR EMBL; AK160394; BAE35764.1; -; mRNA. DR EMBL; AL713870; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC044800; AAH44800.1; -; mRNA. DR CCDS; CCDS24709.1; -. [Q8BHK3-1] DR RefSeq; NP_694810.2; NM_153170.3. [Q8BHK3-1] DR AlphaFoldDB; Q8BHK3; -. DR SMR; Q8BHK3; -. DR STRING; 10090.ENSMUSP00000045613; -. DR TCDB; 2.A.18.8.2; the amino acid/auxin permease (aaap) family. DR iPTMnet; Q8BHK3; -. DR PhosphoSitePlus; Q8BHK3; -. DR MaxQB; Q8BHK3; -. DR PaxDb; 10090-ENSMUSP00000045613; -. DR ProteomicsDB; 256565; -. [Q8BHK3-1] DR ProteomicsDB; 256566; -. [Q8BHK3-2] DR Antibodypedia; 28201; 141 antibodies from 25 providers. DR DNASU; 246049; -. DR Ensembl; ENSMUST00000039305.6; ENSMUSP00000045613.6; ENSMUSG00000020264.6. [Q8BHK3-1] DR GeneID; 246049; -. DR KEGG; mmu:246049; -. DR UCSC; uc007iyz.2; mouse. [Q8BHK3-1] DR UCSC; uc007iza.1; mouse. [Q8BHK3-2] DR AGR; MGI:1891430; -. DR CTD; 153201; -. DR MGI; MGI:1891430; Slc36a2. DR VEuPathDB; HostDB:ENSMUSG00000020264; -. DR eggNOG; KOG1304; Eukaryota. DR GeneTree; ENSGT00940000162044; -. DR HOGENOM; CLU_009646_0_2_1; -. DR InParanoid; Q8BHK3; -. DR OMA; SAMYVPN; -. DR OrthoDB; 3601817at2759; -. DR PhylomeDB; Q8BHK3; -. DR TreeFam; TF314873; -. DR Reactome; R-MMU-352230; Amino acid transport across the plasma membrane. DR Reactome; R-MMU-428559; Proton-coupled neutral amino acid transporters. DR SABIO-RK; Q8BHK3; -. DR BioGRID-ORCS; 246049; 1 hit in 76 CRISPR screens. DR PRO; PR:Q8BHK3; -. DR Proteomes; UP000000589; Chromosome 11. DR RNAct; Q8BHK3; Protein. DR Bgee; ENSMUSG00000020264; Expressed in brown adipose tissue and 111 other cell types or tissues. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0055038; C:recycling endosome membrane; IDA:UniProtKB. DR GO; GO:0005774; C:vacuolar membrane; IBA:GO_Central. DR GO; GO:0005280; F:amino acid:proton symporter activity; IDA:UniProtKB. DR GO; GO:0015187; F:glycine transmembrane transporter activity; IDA:MGI. DR GO; GO:0015180; F:L-alanine transmembrane transporter activity; IDA:MGI. DR GO; GO:0015193; F:L-proline transmembrane transporter activity; IDA:MGI. DR GO; GO:0005297; F:proline:proton symporter activity; IDA:UniProtKB. DR GO; GO:0032973; P:amino acid export across plasma membrane; ISO:MGI. DR GO; GO:0015816; P:glycine transport; IDA:MGI. DR GO; GO:0015808; P:L-alanine transport; IDA:MGI. DR GO; GO:1900925; P:positive regulation of glycine import across plasma membrane; ISO:MGI. DR GO; GO:0035524; P:proline transmembrane transport; ISO:MGI. DR GO; GO:0015824; P:proline transport; IDA:MGI. DR GO; GO:1902600; P:proton transmembrane transport; IDA:MGI. DR GO; GO:0070881; P:regulation of proline transport; ISO:MGI. DR GO; GO:0010155; P:regulation of proton transport; ISO:MGI. DR InterPro; IPR013057; AA_transpt_TM. DR PANTHER; PTHR22950; AMINO ACID TRANSPORTER; 1. DR PANTHER; PTHR22950:SF185; PROTON-COUPLED AMINO ACID TRANSPORTER 2; 1. DR Pfam; PF01490; Aa_trans; 1. DR Genevisible; Q8BHK3; MM. PE 1: Evidence at protein level; KW Alternative splicing; Cell membrane; Endoplasmic reticulum; Endosome; KW Membrane; Reference proteome; Transmembrane; Transmembrane helix. FT CHAIN 1..478 FT /note="Proton-coupled amino acid transporter 2" FT /id="PRO_0000324820" FT TOPO_DOM 1..53 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 54..74 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 75..76 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 77..97 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 98..143 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 144..164 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 165..192 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 193..213 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 214..217 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 218..238 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 239..259 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 260..280 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 281..292 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 293..313 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 314..340 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 341..361 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 362..374 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 375..395 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 396..399 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 400..420 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 421..441 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 442..462 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 463..478 FT /note="Extracellular" FT /evidence="ECO:0000255" FT REGION 1..46 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 23..46 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT VAR_SEQ 278..280 FT /note="LPL -> RFE (in isoform 2)" FT /evidence="ECO:0000303|PubMed:16141072" FT /id="VSP_032374" FT VAR_SEQ 281..478 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:16141072" FT /id="VSP_032375" FT CONFLICT 38 FT /note="S -> T (in Ref. 1; AAM80481 and 2; AAM44854)" FT /evidence="ECO:0000305" FT CONFLICT 189 FT /note="V -> A (in Ref. 1; AAM80481 and 2; AAM44854)" FT /evidence="ECO:0000305" SQ SEQUENCE 478 AA; 52063 MW; 0D4FE1C90F613A8A CRC64; MSVTKSARSP QVATPLNLDL PESAKKLQSQ DPSPANGSSS ESSKKTKGIT GFQTLVHLVK GNMGTGILGL PLAVKNAGIL MGPLSLLVMG LIACHCMHIL VRCAQRFCHR LNKPFMDYGD TVMHGLAFSP NAWLQNHAHW GRRVVSFFLI VTQLGFCCVY IVFLADNLKQ VVEAVNSTTI SCHKNETVVL TPTMDSRLYM LSFLPVLGLL VFVRNLRVLT IFSLLANISM LVSLVIIAQY IIQEIPDASQ LPLVASWKTY PLFFGTAIFS FESIGVVLPL ENKMKDARGF PTILSLGMSI ITTLYIAIGA LGYLRFGDDI KASITLNLPN CWLYQSVKLL YVVGILCTYA LQFYVPAEII IPLAVSQVSK RWALPVDLSI RLALVCLTCM LAILIPRLDL VLSLVGSVSS SALALIIPPL LEVVTYYGEG ISPLTVTKDA LISILGFMGF VVGTYQALDE LIKSGNSPAL SNSTMFIQ //